Shiny Health & Wellness Corp. announced a non-brokered private placement to issue 5,000,000 at an issue price of CAD 0.10 for the gross proceeds of CAD 500,000 on October 4, 2023. Each Unit will consist of one common share and one common share purchase warrant. Each Warrant will entitle the holder thereof to purchase one common share of the company at a price of CAD 0.35 at any time on or before the date which is 24 months following the closing of the Offering. The closing of the Offering is subject to receipt of all necessary regulatory approvals including the TSX Venture Exchange. Finder's fees will be payable in accordance with the policies of the TSXV. The Unit Shares, Warrant Shares and any common shares of the company that are issuable from any finder's warrants will be subject to a hold period of four months and one day following the closing date of the Offering in accordance with applicable securities laws. The company may pay 7% in Cash or Shares may be payable to eligible finders on all or a portion of the offering. The Finder may also receive Finder's warrants entitling it to purchase up to 7% of the shares issued to the purchaser introduced by the Finder under the Offering exercisable at the issue price of CAD 0.35 for a period of 24 months from the Closing Date.

On the same date, the company announced that it has issued 2,250,000 units at an issue price of CAD 0.10 for the gross proceeds of CAD 225,000 in the first tranche. There is no finders fee to be paid on this first tranche. Closing of the First tranche of the Offering is subject to receipt of all necessary regulatory approvals including acceptance of the TSX Venture Exchange.

On November 6, 2023, the company announced that it has received approval from TSX Venture Exchange. The transaction is expected to close on December 1, 2023. The unit shares, warrant shares and any common shares of the company that are issuable from any finder's warrants will be subject to a hold period of four months and one day following the closing date of the offering in accordance with applicable securities laws.

On December 6, 2023, the company announced that it has received approval from the TSX Venture Exchange to extend the closing of its previously announced non-brokered private placement to January 4, 2024. It anticipates that the second and final tranche closing will occur on or before January 4, 2024. The closing of the Offering is subject to receipt of all necessary regulatory approvals including the TSX Venture Exchange. Finder's fees will be payable in accordance with the policies of the TSXV. The Unit Shares, Warrant Shares and any common shares of the Company that are issuable from any finder's warrants will be subject to a hold period of four months and one day following the closing date of the Offering in accordance with applicable securities laws.

On January 4, 2024, the company announced that it does not anticipate any more proceeds from this offering and has closed the transaction in its first tranche. No Finder's fees will be paid in the transaction. The transaction included participation from one placee.